Skip to main content
Signal8

Rhodes Jason P

SEC insider (Form 3/4/5 filer). CIK 0001577014. Director at Dyne Therapeutics, Inc. (DYN) and 1 other issuer. 96 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in WALTHAM, MA.

Companies Rhodes Jason P has filed insider reports for

  • Dyne Therapeutics, Inc. (DYN): Director
  • Generation Bio Co. (GBIO): Director
Rhodes Jason P profile photo

Rhodes Jason P

CIK: 0001577014

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)83 (86.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (4.2%)

Compensation grants

Other (G, F, J, C, D, …)9 (9.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Dyne Therapeutics, Inc. logo
DYN

Dyne Therapeutics, Inc.

Director
Generation Bio Co. logo
GBIO

Generation Bio Co.

Director

Discretionary Trading P&L

Holdings

Transaction History (96 total)

  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Aug 14, 2026
    Sale
    Indirect
    1.4M shares at avg. $25.00$34.0M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Aug 14, 2026
    Sale
    Indirect
    322.5K shares at avg. $25.00$8.1M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Aug 14, 2026
    Sale
    Indirect
    478.4K shares at avg. $25.00$12.0M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Aug 13, 2026
    Sale
    Indirect
    94.4K shares at avg. $26.20$2.5M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Aug 13, 2026
    Sale
    Indirect
    63.6K shares at avg. $26.20$1.7M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Aug 13, 2026
    Sale
    Indirect
    268.4K shares at avg. $26.20$7.0M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Jul 7, 2026
    Sale
    Indirect
    62.5K shares at avg. $23.17$1.4M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Jul 7, 2026
    Sale
    Indirect
    11.7K shares at avg. $23.62$276K
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Jul 7, 2026
    Sale
    Indirect
    124.4K shares at avg. $23.17$2.9M
  • Dyne Therapeutics, Inc. logo
    DYN

    Dyne Therapeutics, Inc.

    Jul 7, 2026
    Sale
    Indirect
    14.8K shares at avg. $23.62$351K

1-10 of 96

…